Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-17

Clinical Trial Update: Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluated ultrarapid insulin delivered by a bihormonal closed-loop system in adults with Type 1 diabetes mellitus, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ultrarapid insulin (ultrarapid insulin)

Snippet

Sponsor: Inreda Diabetic B.V. | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2026-02-17